NASAL

N/A

Manufactured by BEST CHOICE (VALU MERCHANDISERS COMPANY)

9,176 FDA adverse event reports analyzed

Last updated: 2026-04-15

About NASAL

NASAL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BEST CHOICE (VALU MERCHANDISERS COMPANY). The most commonly reported adverse reactions for NASAL include NAUSEA, DYSPNOEA, OFF LABEL USE, DRUG INEFFECTIVE, VOMITING. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for NASAL.

Top Adverse Reactions

NAUSEA326 reports
DYSPNOEA322 reports
OFF LABEL USE293 reports
DRUG INEFFECTIVE269 reports
VOMITING234 reports
FATIGUE227 reports
PAIN222 reports
DIARRHOEA205 reports
PYREXIA194 reports
DIZZINESS193 reports
PNEUMONIA179 reports
HEADACHE175 reports
COUGH167 reports
PARAESTHESIA149 reports
HYPOAESTHESIA148 reports
MALAISE146 reports
MUSCLE SPASMS144 reports
HYPOTENSION142 reports
ASTHENIA140 reports
ABDOMINAL PAIN125 reports
WEIGHT DECREASED125 reports
BACK PAIN115 reports
ANXIETY109 reports
FALL104 reports
DECREASED APPETITE96 reports
DEATH91 reports
HYPERHIDROSIS91 reports
ACUTE KIDNEY INJURY89 reports
CHEST PAIN89 reports
PRURITUS89 reports
CHILLS88 reports
ARTHRALGIA86 reports
INFECTION86 reports
ANAEMIA85 reports
DEHYDRATION85 reports
PRODUCT DOSE OMISSION ISSUE84 reports
URINARY TRACT INFECTION82 reports
FEELING HOT81 reports
NASOPHARYNGITIS80 reports
CONDITION AGGRAVATED79 reports
PAIN IN EXTREMITY78 reports
RASH76 reports
ABDOMINAL PAIN UPPER74 reports
CARDIAC ARREST74 reports
CHEST DISCOMFORT74 reports
SINUSITIS74 reports
WHEEZING74 reports
PALLOR72 reports
SEPSIS72 reports
ASTHMA71 reports
HYPERTENSION70 reports
CONSTIPATION64 reports
ERYTHEMA64 reports
PRODUCTIVE COUGH64 reports
TREMOR64 reports
DYSGEUSIA61 reports
WEIGHT INCREASED61 reports
LOSS OF CONSCIOUSNESS60 reports
FEELING ABNORMAL59 reports
NO ADVERSE EVENT58 reports
TACHYCARDIA58 reports
HYPOXIA57 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION57 reports
HYPERSENSITIVITY56 reports
INSOMNIA56 reports
OXYGEN SATURATION DECREASED55 reports
PERIPHERAL SWELLING55 reports
FLUSHING54 reports
HYPONATRAEMIA54 reports
SOMNOLENCE54 reports
ABDOMINAL DISCOMFORT52 reports
COVID 1952 reports
EPISTAXIS52 reports
ATRIAL FIBRILLATION51 reports
BLOOD PRESSURE INCREASED51 reports
HYPOKALAEMIA51 reports
INFLUENZA51 reports
PRODUCT USE ISSUE51 reports
PULMONARY EMBOLISM51 reports
OEDEMA PERIPHERAL50 reports
URTICARIA50 reports
BLOOD PRESSURE DECREASED49 reports
GAIT DISTURBANCE49 reports
VISION BLURRED49 reports
CONFUSIONAL STATE48 reports
HOSPITALISATION48 reports
TOXICITY TO VARIOUS AGENTS47 reports
INFUSION RELATED REACTION46 reports
BRADYCARDIA45 reports
SEIZURE45 reports
TETANY45 reports
DRUG HYPERSENSITIVITY44 reports
FEBRILE NEUTROPENIA44 reports
HAEMORRHAGE44 reports
MATERNAL EXPOSURE DURING PREGNANCY44 reports
RESPIRATORY FAILURE44 reports
BLOOD CREATININE INCREASED43 reports
GENERAL PHYSICAL HEALTH DETERIORATION42 reports
PRODUCT USE IN UNAPPROVED INDICATION42 reports
THROMBOCYTOPENIA42 reports

Report Outcomes

Out of 3,761 classified reports for NASAL:

Serious 77.2%Non-Serious 22.8%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female2,013 (58.8%)
Male1,409 (41.1%)
Unknown3 (0.1%)

Reports by Age

Age 7066 reports
Age 6261 reports
Age 6860 reports
Age 6059 reports
Age 6659 reports
Age 6959 reports
Age 6558 reports
Age 7258 reports
Age 6756 reports
Age 7155 reports
Age 7453 reports
Age 5052 reports
Age 5851 reports
Age 6448 reports
Age 5745 reports
Age 6145 reports
Age 7345 reports
Age 7544 reports
Age 7643 reports
Age 5342 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with NASAL?

This profile reflects 9,176 FDA FAERS reports that mention NASAL. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for NASAL?

Frequently reported terms in FAERS include NAUSEA, DYSPNOEA, OFF LABEL USE, DRUG INEFFECTIVE, VOMITING, FATIGUE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures NASAL?

Labeling and FAERS entries often list BEST CHOICE (VALU MERCHANDISERS COMPANY) in connection with NASAL. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.